Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin

Cancer Research

Volumn 64, Issue 15, 2004, Pages 5261-5269

  Dimitroff, Charles J ^a,c   Lechpammer, Mirna ^a   Long Woodward, Denise ^a   Kutok, Jeffery L ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOLIPID; GLYCOPROTEIN; GLYCOSPHINGOLIPID; PROTEINASE; SIALIDASE; SIALYL LEWIS X ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE METASTASIS; CANCER GRADING; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FLOW KINETICS; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ADHESION DEFICIENCY; LIGAND BINDING; MICROVASCULATURE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE TUMOR; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SHEAR STRESS; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIGENS, CD15; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BONE MARROW CELLS; BONE NEOPLASMS; CELL ADHESION; CELLS, CULTURED; DISEASE PROGRESSION; E-SELECTIN; ENDOTHELIUM, VASCULAR; GLYCOCONJUGATES; GLYCOPROTEINS; GLYCOSPHINGOLIPIDS; HEMATOPOIETIC STEM CELLS; HUMANS; LIGANDS; MALE; MEMBRANE PROTEINS; OLIGOSACCHARIDES; PROSTATE; PROSTATIC NEOPLASMS;

EID: 3442889380     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0691     Document Type: Article

References (38)

1. Lange PH, Vessella RL. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone. Cancer Metastasis Rev 1999;17:331-6.
2. Reddi AH, Roodman D, Freeman C, Mohla S. Mechanisms of tumor metastasis to the bone: challenges and opportunities. J Bone Miner Res 2003;18:190-4.
3. Keller ET, Zhang S, Cooper CR, et al. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev 2001;20:333-49.
4. Lehr JE, Pienta KJ. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst (Bethesda) 1998;90:118-23.
5. Scott LJ, Clarke NW, George NJ, et al. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer 2001;84:1417-23.
6. Simpson MA, Reiland J, Burger SR, et al. Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. J Biol Chem 2001;276:17949-57.
7. Cooper CR, McLean L, Walsh M, et al. Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro. Clin Cancer Res 2000;6:4839-47.
8. Fornaro M, Manes T, Languino LR. Integrins and prostate cancer metastases. Cancer Metastasis Rev 2001;20:321-31.
9. Cooper CR, Bhatia JK, Muenchen HJ, et al. The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines. Clin Exp Metastasis 2002;19:25-33.
10. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, et al. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 2001;61:4851-7.
11. Glinsky VV, Glinsky GV, Glinskii OV, et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 2003;63:3805-11.
12. Glinskii OV, Turk JR, Pienta KJ, Huxley VH, Glinsky VV, Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells. J Physiol 2004;554:89-99.
13. Schweitzer KM, Drager AM, van der Valk P, et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol 1996;148:165-75.
14. Frenette PS, Subbarao S, Mazo IB, von Andrian UH, Wagner DD. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci USA 1998;95:14423-8.
15. Mazo IB, Gutierrez-Ramos J-C, Frenette PS, et al. Hematopoietic progenitor cells rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 1998;188:465-74.
16. Naiyer AJ, Jo DY, Ahn J, et al. Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. Blood 1999;94:4011-9.
17. Navone NM, Olive M, Ozen M, et al. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res 1997;3:2493-500.
18. Kozlowski JM, Fidler U, Campbell D, et al. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 1984;44:3522-9.
19. Pettaway CA, Pathak S, Greene G, et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996;2:1627-36.
20. Putz E, Witter K, Offner S, et al. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res 1999;59:241-8.
21. Rood PM, Calafat J, von dem Borne AE, Gerritsen WR, van der School CE. Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines. Eur J Clin Investig 2000;30:618-29.
22. Dimitroff CJ, Bernacki RJ, Sackstein R. Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin. Blood 2002;101:602-10.
23. Fuhlbrigge RC, King S, Dimitroff CJ, Kupper TS, Sackstein R. Direct real-time observation of E-and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on western blots. J Immunol 2002;168:5645-51.
24. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K. Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 2003;284:C977-87.
25. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 2001;153:1277-86.
26. Dimitroff CJ, Pera P, Dall'Olio F, et al. Cell surface N-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun 1999;256:631-6.
27. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T-cells. Nature (Lond) 1997;389:978-81.
28. Picker LJ, Warnock RA, Burns AR, et al. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell 1991;66:921-33.
29. Jorgensen T, Berner A, Kaalhus O, et al. Up-regulation of the oligosaccharide sialyl Lewis X: a new prognostic parameter in metastatic prostate cancer. Cancer Res 1995;55:1817-9.
30. Glinskii OV, Huxley VH, Turk JR, et al. Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endothelium. Clin Exp Metastasis 2003;20:451-8.
31. Khaldoyanidi SK, Glinsky VV, Sikora L, et al. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem 2003;278:4127-34.
32. Al-Mehdi AB, Tozawa K, Fisher AB, et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000;6:100-2.
33. Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-derived factor-1/ CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62:1832-7.
34. Mazo IB, von Andrian UH. Adhesion and homing of blood-borne cells in bone marrow. J Leukocyte Biol 1999;66:25-32.
35. Satoh M, Numahata K, Kawamura S, Saito S, Orikasa S. Lack of selectin-dependent adhesion in prostate cancer cells expressing sialyl Le(x). Int J Urol 1998;5:86-91.
36. Idikio HA. Sialyl-Lewis-X, Gleason grade and stage in non-metastatic human prostate cancer, Glycoconjugate J 1997;14:875-7.
37. Martensson S, Bigler SA, Brown M, et al. Sialyl-Lewis(x) and related carbohydrate antigens in the prostate. Hum Pathol 1995;26:735-9.
38. Jorgensen T, Kanagasingam Y, Kaalhus O, et al. Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2. J Urol 1997;158:164-70.